What is the synergistic effect of dual targeting RAF with Type I½ + Type II or Type I + Type II inhibitors on

/What is the synergistic effect of dual targeting RAF with Type I½ + Type II or Type I + Type II inhibitors on ERK activation in NRAS- and KRAS-mutant AML cell lines?

Research Question

What is the synergistic effect of dual targeting RAF with Type I½ + Type II or Type I + Type II inhibitors on ERK activation in NRAS- and KRAS-mutant AML cell lines?

2026